HPBT
REGN icon

Hickory Point Bank & Trust’s Regeneron Pharmaceuticals REGN Stock Holding History

Hickory Point Bank & Trust’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38K Hold
61
– – 0.02% 247
2026
Q1 		$47.1K Buy
+61
New +$46.7K 0.03% 220

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MCI
McDonald Capital Investors Orinda, California $1.37B AUM 1.88% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Hickory Point Bank & Trust's REGN Position: Q2 2026 in Review

Hickory Point Bank & Trust held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 61 shares worth $38K. The position accounts for 0.02% of the portfolio, ranked #247.

Hickory Point Bank & Trust first reported a position in REGN in Q1 2026 and has held it in 2 quarters since. The position peaked at $47.1K in Q1 2026. 518 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Hickory Point Bank & Trust held 61 shares of Regeneron Pharmaceuticals worth $38K as of Q2 2026.
  • Hickory Point Bank & Trust left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
  • Regeneron Pharmaceuticals made up 0.02% of Hickory Point Bank & Trust's portfolio in Q2 2026, its #247 holding.
  • Hickory Point Bank & Trust first reported a position in Regeneron Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Hickory Point Bank & Trust's Regeneron Pharmaceuticals position peaked at $47.1K in Q1 2026.
  • 518 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Hickory Point Bank & Trust's 13F filing for Q2 2026, filed 17 Jul 2026.